Lovastatin protects against experimental plague in mice.
BACKGROUND: Plague is an ectoparasite-borne deadly infection caused by Yersinia pestis, a bacterium classified among the group A bioterrorism agents. Thousands of deaths are reported every year in some African countries. Tetracyclines and cotrimoxazole are used in the secondary prophylaxis of plague...
Main Authors: | Saravanan Ayyadurai, Hubert Lepidi, Claude Nappez, Didier Raoult, Michel Drancourt |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2880009?pdf=render |
Similar Items
-
New Rural Focus of Plague, Algeria
by: Idir Bitam, et al.
Published: (2010-10-01) -
Investigation of Pneumonic Plague, Madagascar
by: Michel Drancourt, et al.
Published: (2018-01-01) -
Immuno-PCR--a new tool for paleomicrobiology: the plague paradigm.
by: Nada Malou, et al.
Published: (2012-01-01) -
Rapid identification and typing of <it>Yersinia pestis </it>and other <it>Yersinia </it>species by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry
by: Drancourt Michel, et al.
Published: (2010-11-01) -
Body Lice, Yersinia pestis Orientalis, and Black Death
by: Saravanan Ayyadurai, et al.
Published: (2010-05-01)